Targeting treatment-resistant social anxiety with sitagliptin: effects on social fear and comorbid depressive-like behavior in a preclinical model
{{output}}
Social anxiety disorder (SAD) is often complicated by comorbid depression and resistance to standard treatments, yet therapeutic strategies that effectively address both core and comorbid symptoms remain limited. We previously demonstrated that sitagliptin, a ... ...
